CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids
Background. Organoid cultures of human pancreatic ductal adenocarcinoma (PDAC) have become a promising tool for tumor subtyping and individualized chemosensitivity testing. PDACs have recently been grouped into different molecular subtypes with clinical impact based on cytokeratin-81 (KRT81) and hep...
Saved in:
Main Authors: | Alexander Hennig, Laura Wolf, Beatrix Jahnke, Heike Polster, Therese Seidlitz, Kristin Werner, Daniela E. Aust, Jochen Hampe, Marius Distler, Jürgen Weitz, Daniel E. Stange, Thilo Welsch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/1024614 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysis
by: Mattijs Bulcaen, et al.
Published: (2025-03-01) -
The Role of CFTR Mutations in Asthma
by: Andrew J Sandford
Published: (2012-01-01) -
A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01) -
Further Evidence That the CFTR Variant c.2620-6T>C Is Benign
by: Violet I. Wallerstein, et al.
Published: (2017-01-01) -
Rescue of Mutant CFTR Channel Activity by Investigational Co-Potentiator Therapy
by: Mafalda Bacalhau, et al.
Published: (2025-01-01)